Actinogen Medical Statistics
Actinogen Medical (3AC) Stock Statistics & Valuation Metrics
Total Valuation
Actinogen Medical has a market cap or net worth of EUR 114.76M. The enterprise value is EUR 90.43M.
- Market Cap
- EUR 114.76M
- Enterprise Value
- EUR 90.43M
Share Statistics
Actinogen Medical has 3,874,168,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,874,168,200
- Owned by Insiders
- 7.45%
- Owned by Institutions
- ―
Financial Efficiency
Actinogen Medical ’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -58.92%.
- Return on Equity (ROE)
- -0.72
- Return on Assets (ROA)
- -0.52
- Return on Invested Capital (ROIC)
- -58.92%
- Return on Capital Employed (ROCE)
- -1.31
- Revenue Per Employee
- 0
- Profits Per Employee
- -2.56M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Actinogen Medical is -10.00. Actinogen Medical ’s PEG ratio is -0.08.
- PE Ratio
- -10.00
- PS Ratio
- 0.00
- PB Ratio
- 7.42
- Price to FCF
- -10.58
- Price to Operating Cash Flow
- -9.03
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Actinogen Medical had revenue of 0 and earned -15.38M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -419.27K
- Operating Income
- -28.11M
- Pretax Income
- -28.05M
- Net Income
- -15.38M
- EBITDA
- -27.69M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -17.56M and capital expenditures -9,292, giving a free cash flow of -17.57M billion.
- Operating Cash Flow
- -17.56M
- Free Cash Flow
- -17.57M
- Free Cash Flow per Share
- -0.01
Dividends & Yields
Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.65%
- Earnings Yield
- -9.91%
Stock Price Statistics
- Beta
- 0.08
- 52-Week Price Change
- 20.00%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.02
- Relative Strength Index (RSI)
- 47.46
- Average Volume (3m)
- 69.84K
Important Dates
Actinogen Medical upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Actinogen Medical as a current ratio of 3.45, with Debt / Equity ratio of 22.38%
- Current Ratio
- 3.45
- Quick Ratio
- 3.45
- Debt to Market Cap
- 0.05
- Net Debt to EBITDA
- 0.43
- Interest Coverage Ratio
- -60.34
Taxes
In the past 12 months, Actinogen Medical has paid -12.67M in taxes.
- Income Tax
- -12.67M
- Effective Tax Rate
- 0.45
Enterprise Valuation
Actinogen Medical EV to EBITDA ratio is -6.14, with an EV/FCF ratio of -9.68.
- EV to Sales
- 0.00
- EV to EBITDA
- -6.14
- EV to Free Cash Flow
- -9.68
- EV to Operating Cash Flow
- -9.69
Balance Sheet
Actinogen Medical has EUR 16.73M in cash and marketable securities with EUR 4.78M in debt, giving a net cash position of EUR 11.95M billion.
- Cash & Marketable Securities
- EUR 16.73M
- Total Debt
- EUR 4.78M
- Net Cash
- EUR 11.95M
- Net Cash Per Share
- EUR 0.00
- Tangible Book Value Per Share
- EUR 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Actinogen Medical is EUR 0.05, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 0.05
- Price Target Upside
- 105.58% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 10.00%
Scores
- Smart Score
- 6
- AI Score
- ―
